Smartee Expands Orthodontic Tech Portfolio with Mandibular Repositioning and Sleep Solutions

  • Smartee showcased its GS Mandibular Repositioning Technology at EOS 2026, targeting Class II and III malocclusion with integrated mandibular repositioning components.
  • The company presented its Sleep Aligner Series for primary snoring and mild to moderate OSA, featuring digitally customized designs and dual-splint locking mechanisms.
  • Smartee has established a manufacturing hub in Madrid, Spain, to support localized production and service capabilities across Europe.
  • The company will host the Smartee European Summit in September 2026 to discuss emerging treatment approaches and developments in clear aligner therapy.

Smartee's focus on mandibular repositioning technology and sleep solutions reflects a broader industry shift towards integrated digital orthodontic treatments. The company's strategic investments in European manufacturing and professional education underscore its commitment to expanding access to diversified treatment options, positioning itself as a key player in the evolving landscape of digital orthodontics.

Market Expansion
The pace at which Smartee can scale its European operations through the Madrid manufacturing hub and subsequent regional partnerships.
Regulatory Compliance
Whether Smartee's Sleep Aligner Series can navigate varying local regulations for mild to moderate OSA treatment across different markets.
Technological Integration
How the integration of mandibular repositioning components with clear aligners will impact treatment planning and adoption rates among orthodontic professionals.